EDGAR Filing Documents for 0001410578-23-000324

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001410578-23-000324

Filing Date

2023-03-22

Accepted

2023-03-22 08:00:36

Documents

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	mrkr-20221231x10k.htm iXBRL	10-K	2322942
2	EX-21.1	mrkr-20221231xex21d1.htm	EX-21.1	2030
3	EX-23.1	mrkr-20221231xex23d1.htm	EX-23.1	4847
4	EX-31.1	mrkr-20221231xex31d1.htm	EX-31.1	11864
5	EX-31.2	mrkr-20221231xex31d2.htm	EX-31.2	12089
6	EX-32.1	mrkr-20221231xex32d1.htm	EX-32.1	5625
7	EX-32.2	mrkr-20221231xex32d2.htm	EX-32.2	6302
8	GRAPHIC	mrkr-20221231x10k001.jpg	GRAPHIC	15804
9	GRAPHIC	mrkr-20221231x10k002.jpg	GRAPHIC	47674
10	GRAPHIC	mrkr-20221231x10k003.jpg	GRAPHIC	47515
11	GRAPHIC	mrkr-20221231x10k004.jpg	GRAPHIC	18739
12	GRAPHIC	mrkr-20221231x10k005.jpg	GRAPHIC	21860
13	GRAPHIC	mrkr-20221231x10k006.jpg	GRAPHIC	44838
14	GRAPHIC	mrkr-20221231x10k007.jpg	GRAPHIC	31661
15	GRAPHIC	mrkr-20221231x10k008.jpg	GRAPHIC	28957
16	GRAPHIC	mrkr-20221231x10k009.jpg	GRAPHIC	18484
17	GRAPHIC	mrkr-20221231x10k010.jpg	GRAPHIC	74658
18	GRAPHIC	mrkr-20221231x10k011.jpg	GRAPHIC	101808
	Complete submission text file	0001410578-23-000324.txt		9157909

Data Files

Seq	Description	Document	Type	Size
19	EX-101.SCH	mrkr-20221231.xsd	EX-101.SCH	64448
20	EX-101.CAL	mrkr-20221231_cal.xml	EX-101.CAL	54263
21	EX-101.DEF	mrkr-20221231_def.xml	EX-101.DEF	224188
22	EX-101.LAB	mrkr-20221231_lab.xml	EX-101.LAB	422247
23	EX-101.PRE	mrkr-20221231_pre.xml	EX-101.PRE	392015
88	EXTRACTED XBRL INSTANCE DOCUMENT	mrkr-20221231x10k_htm.xml	XML	1088351

Mailing Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032

Business Address 4551 KENNEDY COMMERCE DR. HOUSTON TX 77032 (713) 400-6400

Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)